Literature DB >> 18329531

The pathology of scleroderma vascular disease.

Jo Nadine Fleming1, Stephen Mark Schwartz.   

Abstract

Systemic sclerosis is characterized by three distinct pathologic processes: fibrosis, cellular/humoral autoimmunity, and specific vascular changes. Although a mild vasculitis may sometimes be present, the vascular pathology of scleroderma is not necessarily inflammatory and is best characterized as a vasculopathy. In this article, the authors propose that SSc vasculopathy is the result of an early event involving vascular injury that eventuates in a vicious cycle mediated in part by the immune process. The subsequent vascular malformation and rarefaction may be a function of systemic angiogenic dysregulation, with over expression of vascular endothelial growth factor but a lack of proper interactions with smooth muscle cells needed to stabilize and organize blood vessels.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18329531     DOI: 10.1016/j.rdc.2008.01.001

Source DB:  PubMed          Journal:  Rheum Dis Clin North Am        ISSN: 0889-857X            Impact factor:   2.670


  24 in total

Review 1.  The pathogenesis, diagnosis and treatment of Raynaud phenomenon.

Authors:  Ariane L Herrick
Journal:  Nat Rev Rheumatol       Date:  2012-07-10       Impact factor: 20.543

Review 2.  Dendritic cells: novel players in fibrosis and scleroderma.

Authors:  Theresa T Lu
Journal:  Curr Rheumatol Rep       Date:  2012-02       Impact factor: 4.592

Review 3.  Pathogenesis of Systemic Sclerosis.

Authors:  Debendra Pattanaik; Monica Brown; Bradley C Postlethwaite; Arnold E Postlethwaite
Journal:  Front Immunol       Date:  2015-06-08       Impact factor: 7.561

4.  Endothelial cell-specific activation of transforming growth factor-β signaling in mice induces cutaneous, visceral, and microvascular fibrosis.

Authors:  Peter J Wermuth; Kellan R Carney; Fabian A Mendoza; Sonsoles Piera-Velazquez; Sergio A Jimenez
Journal:  Lab Invest       Date:  2017-03-27       Impact factor: 5.662

Review 5.  Biomarkers in systemic sclerosis.

Authors:  Susan V Castro; Sergio A Jimenez
Journal:  Biomark Med       Date:  2010-02       Impact factor: 2.851

6.  Perivascular T-cell infiltration leads to sustained pulmonary artery remodeling after endothelial cell damage.

Authors:  Michael J Cuttica; Thomas Langenickel; Audrey Noguchi; Roberto F Machado; Mark T Gladwin; Manfred Boehm
Journal:  Am J Respir Cell Mol Biol       Date:  2010-09-02       Impact factor: 6.914

7.  Increased expression of NAPDH oxidase 4 in systemic sclerosis dermal fibroblasts: regulation by transforming growth factor β.

Authors:  Sonsoles Piera-Velazquez; Alma Makul; Sergio A Jiménez
Journal:  Arthritis Rheumatol       Date:  2015-10       Impact factor: 10.995

8.  Systemic vasculopathy with altered vasoreactivity in a transgenic mouse model of scleroderma.

Authors:  Emma C Derrett-Smith; Audrey Dooley; Korsa Khan; Xu Shi-wen; David Abraham; Christopher P Denton
Journal:  Arthritis Res Ther       Date:  2010-04-15       Impact factor: 5.156

Review 9.  [Scleroderma and fibrosing diseases].

Authors:  U A Walker; P Knöss; M Jakobs; V Krenn
Journal:  Z Rheumatol       Date:  2009-06       Impact factor: 1.372

10.  Lymphatic and blood vessels in scleroderma skin, a morphometric analysis.

Authors:  Antonella Rossi; Francesca Sozio; Piersante Sestini; Elisabetta A Renzoni; Korsa Khan; Christopher P Denton; David J Abraham; Elisabetta Weber
Journal:  Hum Pathol       Date:  2009-12-11       Impact factor: 3.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.